Guanidinoacetic Acid Market Overview
The Guanidinoacetic Acid Market was valued at USD 44.14 Million in 2025 and is projected to reach USD 62.53 Million by 2032, growing at a CAGR of 5.1% during 2026–2032, with Asia-Pacific holding the largest share.
Primary Drivers
- Rising demand for animal feed additives that improve energy metabolism and growth performance is driving guanidinoacetic acid adoption.
- Growing livestock and poultry production globally is boosting demand for creatine precursor feed supplements.
- Increasing awareness of guanidinoacetic acid's benefits over conventional creatine supplementation is expanding adoption in premium feed formulations.
Primary Challenges
- Limited farmer awareness and technical knowledge about guanidinoacetic acid benefits can slow adoption in developing markets.
- Regulatory approval variability for feed additives across different countries complicates market entry.
- Price volatility of raw material inputs affects production cost stability for manufacturers.
This report includes a dedicated chapter covering supply chain exposure, export controls, sanctions risk, and regulatory shifts affecting Guanidinoacetic Acid Market.
Guanidinoacetic Acid Market Strategic Outlook
Growth trajectory, 2026–2032
How this market is covered
Revenue split by type
Revenue by end use
Guanidinoacetic acid (GAA) or Glycocyamine is the biochemical precursor of creatine, which is phosphorylated. It plays an important role as a high-energy carrier in the muscle. Glycocyamine is actually a metabolite of glycine in which the amino group has been converted into a guanidine.Guanidinoacetic acid can be used to increase muscle strength and to reduce muscle fatigue. And add guanidinoacetic acid into fodder can make lean pig's body improve significantly. GAA might be considered as an innovative way to improve exercise performance.It has recently been suggested as a possible alternative to creatine to tackle brain creatine levels in experimental medicine. Due to upgraded bioavailability and convenient utilization of the compound, taking GAA orally might be benefitial for AGAT patients. But it has several drawbacks like brain methylation issues, neurotoxicity, and hyperhomocysteinemia.
From studies it has been observed that a combination of betaine and glycocyamine improves the symptoms of patients with chronic illness, including heart disease, without toxicity. Betaine provides methyl group to glycocyamine, via methionine, for the formation of creatine. Because of this, such treatment led to less fatigue, greater strength and endurance, and an improved sense of well-being. It is also useful for the patients with cardiac decompensation (arteriosclerosis or rheumatic disease) and congestive heart failure for improving cardiac function. It is also helpful in gained weight (improved nitrogen balance) and saw lessened symptoms of arthritis and asthma and increased libido. People suffering from hypertension experienced transient reduced blood pressure.It also increase of glucose tolerance in both diabetic and without diabetes subjects.
Geogrphically, Guanidinoacetic Acid Market analysis covers regions- North America (USA, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).
Guanidinoacetic Acid Market : By Product Type
- Feed Grade
- Pharmaceutical Grade
Global Guanidinoacetic Acid Market: Companies Covered
- Evonik (Germany)
- GENDONE (China)
- HebeiDaxiao (China)
- TianchengChempharm (China)
- Lubon Industry (China)
- Hubei Yuanhua (China)
- Jiangsu Yuanyang (China)
- Shijiazhuang Zexing (China)
Geographical analysis of Guanidinoacetic Acid Market includes :
-
North America
- U.S.A.
- Canada
- Europe
- France
- Germany
- Spain
- UK
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South East Asia
- Latin America
- Brazil
- Middle East and Africa
Guanidinoacetic Acid Market Report delivers a comprehensive analysis of the following parameters :
- Market Forecast for 2017-24
- Market growth drivers
- Challenges and Opportunities
- Emerging and Current Market trends
- Market player Capacity, Production, Revenue (Value)
- Supply (Production), Consumption, Export, Import analysis
- End-user/application Analysis
Specialty Chemicals Landscape
Report Coverage
| Parameter | Details |
|---|---|
| Base Year | 2025 |
| Historical Data | 2020 – 2025 |
| Forecast Period | 2026 – 2032 |
| Base Year Value | USD 44.14 Million |
| Forecast Value | USD 62.53 Million |
| CAGR | 5.1% |
| Regional Scope | North America · Europe · Asia-Pacific · Latin America · MEA · RoW |
Frequently Asked Questions
Guanidinoacetic Acid Market was valued at USD 44.14 Million in 2025 and is estimated to reach USD 62.53 Million by 2032.
Guanidinoacetic Acid Market is projected to grow at a CAGR of 5.1% during 2025–2032.
1. Rising demand for animal feed additives that improve energy metabolism and growth performance is driving guanidinoacetic acid adoption. 2. Growing livestock and poultry production globally is boosting demand for creatine precursor feed supplements. 3. Increasing awareness of guanidinoacetic acid's benefits over conventional creatine supplementation is expanding adoption in premium feed formulations.
Yes. The report includes a dedicated section on geopolitical risk factors and their impact on supply chains, pricing, and regional demand dynamics.